Ocular Therapeutix Statistics
Total Valuation
OCUL has a market cap or net worth of $2.52 billion. The enterprise value is $2.25 billion.
Important Dates
The last earnings date was Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OCUL has 213.05 million shares outstanding. The number of shares has increased by 26.34% in one year.
| Current Share Class | 213.05M |
| Shares Outstanding | 213.05M |
| Shares Change (YoY) | +26.34% |
| Shares Change (QoQ) | +6.56% |
| Owned by Insiders (%) | 0.90% |
| Owned by Institutions (%) | 76.73% |
| Float | 186.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 36.99 |
| Forward PS | 39.82 |
| PB Ratio | 8.06 |
| P/TBV Ratio | 9.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 40.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.85, with a Debt / Equity ratio of 0.30.
| Current Ratio | 7.85 |
| Quick Ratio | 7.62 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.80 |
Financial Efficiency
Return on equity (ROE) is -81.83% and return on invested capital (ROIC) is -43.27%.
| Return on Equity (ROE) | -81.83% |
| Return on Assets (ROA) | -36.61% |
| Return on Invested Capital (ROIC) | -43.27% |
| Return on Capital Employed (ROCE) | -72.99% |
| Revenue Per Employee | $203,588 |
| Profits Per Employee | -$911,215 |
| Employee Count | 274 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 65.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.51% in the last 52 weeks. The beta is 0.96, so OCUL's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +27.51% |
| 50-Day Moving Average | 11.75 |
| 200-Day Moving Average | 9.71 |
| Relative Strength Index (RSI) | 53.18 |
| Average Volume (20 Days) | 2,050,359 |
Short Selling Information
The latest short interest is 13.77 million, so 6.47% of the outstanding shares have been sold short.
| Short Interest | 13.77M |
| Short Previous Month | 13.59M |
| Short % of Shares Out | 6.47% |
| Short % of Float | 7.40% |
| Short Ratio (days to cover) | 4.00 |
Income Statement
In the last 12 months, OCUL had revenue of $55.78 million and -$249.67 million in losses. Loss per share was -$1.44.
| Revenue | 55.78M |
| Gross Profit | -137.71M |
| Operating Income | -263.93M |
| Pretax Income | -249.67M |
| Net Income | -249.67M |
| EBITDA | -259.91M |
| EBIT | -263.93M |
| Loss Per Share | -$1.44 |
Full Income StatementBalance Sheet
The company has $344.77 million in cash and $77.01 million in debt, giving a net cash position of $267.76 million or $1.26 per share.
| Cash & Cash Equivalents | 344.77M |
| Total Debt | 77.01M |
| Net Cash | 267.76M |
| Net Cash Per Share | $1.26 |
| Equity (Book Value) | 258.23M |
| Book Value Per Share | 1.48 |
| Working Capital | 337.69M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$190.06 million and capital expenditures -$9.37 million, giving a free cash flow of -$199.44 million.
| Operating Cash Flow | -190.06M |
| Capital Expenditures | -9.37M |
| Free Cash Flow | -199.44M |
| FCF Per Share | -$0.94 |
Full Cash Flow StatementMargins
| Gross Margin | -246.87% |
| Operating Margin | -473.14% |
| Pretax Margin | -447.58% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.34% |
| Shareholder Yield | -26.34% |
| Earnings Yield | -9.93% |
| FCF Yield | -7.93% |
Analyst Forecast
The average price target for OCUL is $22.33, which is 88.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.33 |
| Price Target Difference | 88.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 51.33% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OCUL has an Altman Z-Score of 1.21 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.21 |
| Piotroski F-Score | 1 |
